Bioventix PLC (LON:BVXP – Get Free Report)’s share price reached a new 52-week low on Tuesday . The stock traded as low as GBX 2,552 ($32.98) and last traded at GBX 2,603.90 ($33.65), with a volume of 13413 shares traded. The stock had previously closed at GBX 2,590 ($33.47).
Bioventix Stock Performance
The stock has a 50-day moving average of GBX 2,949.16 and a two-hundred day moving average of GBX 3,401.83. The company has a market cap of £136.35 million, a P/E ratio of 16.84 and a beta of 0.35.
Bioventix Company Profile
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Featured Articles
- Five stocks we like better than Bioventix
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- NVIDIA Insiders Sell: This Is What It Means for the Market
- What Are Dividend Champions? How to Invest in the Champions
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
